New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Verona Pharma plc
VRNA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

5B

Biotechnology

Next Earning date - 06 Mar 2025

5B

Biotechnology

Next Earning date - 06 Mar 2025

60.26USD

Shape-0.99 ( -1.62%)
Market Closed (as of Feb 07, 22:05 EDT)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

-13%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated February 10, 2025
1W 0.53 % 1M 29.06 % 3M 51.14 % 1Y 250.35 %

Key Metrics

Shape
  • Market Cap

    4.93B


  • Shares Outstanding

    81.83M


  • Share in Float

    68.91M


  • Dividende

    0


  • Earning Date

    06 Mar 2025


  • Price Target

    60.26


  • Average Volume

    1.23M


  • Beta

    0.424


  • Range

    11.39-62


  • Industry

    Biotechnology


  • Website

    https://www.veronapharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

VRNA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$187M

Shape3222%

2025-Revenue

$0.03

Shape153%

2025-EPS

$37M

Shape-8%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

71.00(17.82%)

Number of analyst

2

Last analyst upgrade/downgrade

Wells Fargo

initialise

Previous: Not converted

2024-10-03

Now: Overweight

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-26

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.16
vs -0.40

Q1.23

arrow
arrow

N/A

-0.24
vs -0.40

Q2.23

arrow
arrow

N/A

-0.11
vs -0.32

Q3.23

arrow
arrow

N/A

-0.18
vs -0.24

Q4.23

arrow
arrow

N/A

-0.16
vs -0.16

Q1.24

arrow
arrow

N/A

-0.32
vs -0.24

Q2.24

arrow
arrow

N/A

-0.88
vs -0.11

Q3.24

arrow
arrow

N/A

-0.56
vs -0.18

Q4.24

arrow
arrow

N/A

-0.06
vs -0.16

Q1.25

arrow
arrow

N/A

-0.04
vs -0.32

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

458K  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

+105%

940.1K  vs 458K

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

5.6M  vs NA

Q4.24

arrow
arrow

+2472%

24.2M  vs 940.1K

Q1.25

arrow
arrow

NA

35M  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-5%

-0.05
vs -0.07

Q1.23

arrow
arrow

-6%

-0.06
vs -0.05

Q2.23

arrow
arrow

-3%

-0.03
vs -0.06

Q3.23

arrow
arrow

-6%

-0.06
vs -0.03

Q4.23

arrow
arrow

-6%

-0.06
vs -0.06

Q1.24

arrow
arrow

-11%

-0.11
vs -0.06

Q2.24

arrow
arrow

-42%

-0.42
vs -0.11

Q3.24

arrow
arrow

-33%

-0.33
vs -0.42

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

102

102
vs 72

42%

Q1.23

arrow
arrow

98

98
vs 102

-4%

Q2.23

arrow
arrow

108

108
vs 98

10%

Q3.23

arrow
arrow

108

108
vs 108

NA

Q4.23

arrow
arrow

123

123
vs 108

14%

Q1.24

arrow
arrow

117

117
vs 123

-5%

Q2.24

arrow
arrow

132

132
vs 117

13%

Q3.24

arrow
arrow

162

162
vs 132

23%

Earnings Growth

Latest News